Pharmaceutical industry in Nigeria

Last updated

The pharmaceutical industry in Nigeria is oligopoly, being a multi-product industry. It is characterized by a combination of Stackelberg equilibrium (Leadership/Followership), Cournot (classical) model, quasi-competitive model, for various groups of products, and generally by market price stability of the kinked demand curve model, ruling out collusion model and stackelberg disequilibrium. Concerning the investigation of the prospects of the industry to contribute to national development in terms of contribution to growth as a leading sector and promotion of self-reliance through net export earnings, findings show that the sector's prospects are poor in this respect as it is not above average for the Nigerian economy.

Desirable policy strategies required for efficient conduct and performance of the industry include better government funding of research and development through the National Institute for Pharmaceutical Research and Development in collaboration with universities, support for the establishment of professional distribution network, completion of the third phase of petrochemical project, and the need for the Raw Material Research and Development Council (RMRDC) to also focus on active pharmaceutical ingredients. [1]

Related Research Articles

<span class="mw-page-title-main">Economy of Nigeria</span> National economy of Nigeria

The economy of Nigeria is a middle-income, mixed economy and emerging market with expanding manufacturing, financial, service, communications, technology, and entertainment sectors. It is ranked as the 31st-largest economy in the world in terms of nominal GDP, the largest in Africa and the 27th-largest in terms of purchasing power parity.

<span class="mw-page-title-main">Import substitution industrialization</span> Trade and economic policy

Import substitution industrialization (ISI) is a trade and economic policy that advocates replacing foreign imports with domestic production. It is based on the premise that a country should attempt to reduce its foreign dependency through the local production of industrialized products. The term primarily refers to 20th-century development economics policies, but it has been advocated since the 18th century by economists such as Friedrich List and Alexander Hamilton.

The software industry includes businesses for development, maintenance and publication of software that are using different business models, mainly either "license/maintenance based" (on-premises) or "Cloud based". The industry also includes software services, such as training, documentation, consulting and data recovery. The software and computer services industry spends more than 11% of its net sales for Research & Development which is in comparison with other industries the second highest share after pharmaceuticals & biotechnology.

<span class="mw-page-title-main">Manufacturing in Japan</span> Overview of the manufacturing industry of Japan

Japan's major export industries include automobiles, consumer electronics, computers, semiconductors, copper, and iron and steel. Additional key industries in Japan's economy are petrochemicals, pharmaceuticals, bioindustry, shipbuilding, aerospace, textiles, and processed foods.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Drug development</span> Process of bringing a new pharmaceutical drug to the market

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug. The entire process – from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials – to approved vaccine or drug typically takes more than a decade.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">National Agency for Food and Drug Administration and Control</span> Government agency in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian federal agency under the Federal Ministry of Health that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, chemicals, and packaged water.

<span class="mw-page-title-main">Agriculture in Nigeria</span> Overview of agriculture in Nigeria

Maize, cassava, guinea corn, and yam are the major crops farmed in Nigeria, with 70% of the households engaged in crop farming. In the south, 7.3% of the households practice fishing, while 69.3% of the households own or raise livestock in northwest Nigeria.

<span class="mw-page-title-main">Agency for Science, Technology and Research</span> Government agency in Singapore

The Agency for Science, Technology and Research (A*STAR) is a statutory board under the Ministry of Trade and Industry of Singapore.

The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within the country. Manufacturers produce insulin, hormones, and cancer drugs. This sector provides 97% of the total medicinal requirement of the local market. The industry also exports medicines to global markets, including Europe. Pharmaceutical companies are expanding their business with the aim to expand the export market.

<span class="mw-page-title-main">R&D intensity</span> Expenditures on a firms research and development divided by its sales

Research and development intensity is generally defined as expenditures by a firm on its research and development (R&D) divided by the firm's sales. There are two types of R&D intensity: direct and indirect. R&D intensity varies, in general, according to a firm's industry sector, product knowledge, manufacturing, and technology, and is a metric that can be used to gauge the level of a company's investment to spur innovation in and through basic and applied research. A further aim of R&D spending, ultimately, is to increase productivity as well as an organization's salable output.

The National Institute for Pharmaceutical Technology and Education (NIPTE) is a non-profit scientific and research and development organization that was established in 2005 and incorporated in June 2007 in the State of Indiana. Its offices are currently located in Minneapolis, Minnesota.

Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.

<span class="mw-page-title-main">Federal Ministry of Health (Nigeria)</span>


The Federal Ministry of Health is one of the Federal Ministries of Nigeria concerned with the formulation and implementation of policies related to health. It is headed by two Ministers appointed by the President, assisted by a Permanent Secretary, who is a career civil servant. The current Minister of Health is Muhammad Ali Pate. The current Minister of State for Health is Tunji Alausa. The Federal Ministry Of Health has over 800 workers consisting of closely 430 women and 370 men.[5]

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

<span class="mw-page-title-main">Foreign trade of India</span> Details of the trade planning and execution by India

Foreign trade in India includes all imports and exports to and from India. At the level of Central Government it is administered by the Ministry of Commerce and Industry. Foreign trade accounted for 48.8% of India's GDP in 2018.

The North East of England Process Industry Cluster (NEPIC) is an economic cluster developed in accordance with Michael Porter's theories and strategies regarding industrial clusters. The chemistry-using sectors in North East England, where more than 1,400 businesses are headquartered in the industry's supply chain, formed this Process Industry Cluster. In the north-east of England, the industry employs approximately 35,000 direct workers and around 190,000 indirect workers, who collectively account for more than one-third of the area's industrial economy. Companies in the cluster produce 35% of the pharmaceuticals and 50% of the petrochemicals used in the UK, making this area the only net exporter of goods from the country. The area has more than £13 billion in exports.

Specialty chemicals are particular chemical products which provide a wide variety of effects on which many other industry sectors rely. Some of the categories of speciality chemicals are adhesives, agrichemicals, cleaning materials, colors, cosmetic additives, construction chemicals, elastomers, flavors, food additives, fragrances, industrial gases, lubricants, paints, polymers, surfactants, and textile auxiliaries. Other industrial sectors such as automotive, aerospace, food, cosmetics, agriculture, manufacturing, and textiles are highly dependent on such products.

<span class="mw-page-title-main">Nigeria–Spain relations</span> Bilateral relations

Nigeria–Spain relations are the bilateral and diplomatic relations between these two countries. Nigeria has an embassy in Madrid. Spain has an embassy in Abuja and a consulate-general in Lagos.

References

  1. Ugoji, Ngozi. "Market structure, conduct, and performance of the pharmaceutical industry in Nigeria". Unilag SPGS (Thesis & Dissertation): 288.